IHS Chemical Week

EnviroTech :: Innovation

Samsung Enters Contract Biopharma Sector

8:24 AM MST | March 3, 2011 | Alex Scott

Electronics giant Samsung says it has formed a joint venture company with Quintiles, a top-tier pharma services group to support its entry into the contract manufacture of biopharmaceuticals. Samsung aplans to commercialize generic biopharmaceuticals - dubbed biosimilars - by 2016, and expand into innovative biologics thereafter.   Under an agreement signed during the past week, Quintiles takes a minority 10% stake in teh jv and will investment of approximately $30 million in the business. Samsung will own the other 90% of the jv company...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa